Increases in TH immunoreactivity, neuromelanin and degeneration in the substantia nigra of middle aged mice

Neuroscience Letters

Volumn 396, Issue 3, 2006, Pages 263-268

  Kim, Sung Tae ^a   Choi, Ji Hyun ^a   Kim, Donghou ^a   Hwang, Onyou ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Aging; Degeneration; Neuromelanin; Substantia nigra; Tyrosine hydroxylase

Indexed keywords

DOPAMINE; NEUROMELANIN; TYROSINE 3 MONOOXYGENASE;

AGING; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL DENSITY; CELL VOLUME; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME SYNTHESIS; IMMUNOREACTIVITY; MOUSE; NERVE DEGENERATION; NERVE FIBER; NONHUMAN; OPTICAL DENSITY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SILVER STAINING; SUBSTANTIA NIGRA;

AGE FACTORS; AGING; ANIMALS; CELL COUNT; FEMALE; IMMUNOHISTOCHEMISTRY; MELANINS; MICE; MICE, INBRED ICR; NERVE DEGENERATION; NEURONS; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

EID: 33644665032     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2005.11.053     Document Type: Article

References (38)

1. G. Benzi, O. Pastoris, F. Marzatico, and R.F. Villa Influence of aging and drug treatment on the cerebral glutathione system Neurobiol. Aging 9 1988 371 375
2. C.R. Cabello, J.J. Thune, H. Pakkenberg, and B. Pakkenberg Ageing of substantia nigra in humans: cell loss may be compensated by hypertrophy Neuropathol. Appl. Neurobiol. 28 2002 283 291
3. C.J. Churukian Pigments and minerals J.D. Bancroft M. Gamble Theory and Practice of Histological Techniques 2002 Churchill Livingstone London 243 267
4. C.P. De La Cruz, E. Revilla, J.L. Venero, A. Ayala, J. Cano, and A. Machado Oxidative inactivation of tyrosine hydroxylase in substantia nigra of aged rat Free Radic. Biol. Med. 20 1996 53 61
5. J.S. de Olmos, C.A. Beltramino, and S.D.O. de Lorenzo Use of an Amino-Cupric-Silver technique for the detection of early and semiacute neuronal degeneration caused by neurotoxicants, hypoxia, and physical trauma Neurotoxicol. Teratol. 16 1994 545 561
6. B. Drukarch, and F.L. van Muiswinkel Drug treatment of Parkinson's disease. Time for phase II Biochem. Pharmacol. 59 2000 1023 1031
7. A.J. Dunn, and S.E. File Cold restraint alters dopamine metabolism in frontal cortex, nucleus accumbens and neostriatum Physiol. Behav. 31 1983 511 513
8. J.M. Fearnley, and A.J. Lees Ageing and Parkinson's disease: substantia nigra regional selectivity Brain 114 1991 2283 2301
9. B. Fornstedt, E. Rosengren, and A. Carlsson Occurrence and distribution of 5-S-cysteinyl derivatives of dopamine, dopa and dopac in the brains of eight mammalian species Neuropharmacology 25 1986 451 454
10. D.G. Graham, S.M. Tiffany, W.R. Bell Jr., and W.F. Gutknecht Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro Mol. Pharmacol. 14 1978 644 653
11. C.E. Greenwood, W.G. Tatton, N.A. Seniuk, and F.G. Biddle Increased dopamine synthesis in aging substantia nigra neurons Neurobiol. Aging 12 1991 557 565
12. E. Grünblatt, S. Mandel, and M.B. Youdim MPTP and 6-hydroxydopamine-induced neurodegeneration as models for Parkinson's disease: neuroprotective strategies J. Neurol. 247 Suppl. 2 2000 II95 II102
13. M. Gupta, M.H. Stoler, L.H. Fossom, and A.W. Tank Tyrosine hydroxylase mRNA in the dopaminergic neurons of young adult and aged mice by in situ hybridization Neurosci. Lett. 119 1990 49 52
14. J.M. Harper, A.T. Galecki, D.T. Burke, and R.A. Miller Body weight, hormones and T cell subsets as predictors of life span in genetically heterogeneous mice Mech. Ageing Dev. 125 2004 381 390
15. T. Hatai, A. Matsuzawa, S. Inoshita, Y. Mochida, T. Kuroda, K. Sakamaki, K. Kuida, S. Yonehara, H. Ichijo, and K. Takeda Execution of apoptosis signal-regulating kinase 1 (ASK1)-induced apoptosis by the mitochondria- dependent caspase activation J. Biol. Chem. 275 2000 26576 26581
16. O. Hwang, H. Baker, S. Gross, and T.H. Joh Localization of GTP cyclohydrolase in monoaminergic but not nitric oxide-producing cells Synapse 28 1998 140 153
17. W. Kedzierski, and J.C. Porter Quantitative study of tyrosine hydroxylase mRNA in catecholaminergic neurons and adrenals during development and aging Brain Res. Mol. Brain Res. 7 1990 45 51
18. S.T. Kim, J.H. Choi, J.W. Chang, S.W. Kim, and O. Hwang Immobilization stress causes increases in tetrahydrobiopterin, dopamine, and neuromelanin and oxidative damage in the nigrostriatal system J. Neurochem. 95 2005 89 98
19. 14C]diquat in frogs and mice: accumulation in neuromelanin Neurosci. Lett. 93 1988 1 6
20. D.M. Mann, and P.O. Yates Lipoprotein pigments - their relationship to ageing in the human nervous system. II. The melanin content of pigmented nerve cells Brain 97 1974 489 498
21. P.L. McGeer, and E.G. McGeer Enzymes associated with the metabolism of catecholamines, acetylcholine and GABA in human controls and patients with Parkinson's Disease and Huntington's Chorea J. Neurochem. 26 1976 65 76
22. P.L. McGeer, E.G. McGeer, and J.S. Suzuki Aging and extrapyramidal function Arch. Neurol. 34 1977 33 35
23. E.G. McGeer, P.L. McGeer, and J.A. Wada Distribution of tyrosine hydroxylase in human and animal brain J. Neurochem. 18 1971 1647 1658
24. R.A. Miller, J.M. Harper, R.C. Dysko, S.J. Durkee, and S.N. Austad Longer life spans and delayed maturation in wild-derived mice Exp. Biol. Med. (Maywood) 227 2002 500 508
25. B. Nankova, R. Kvetnansky, A. McMahon, E. Viskupic, B. Hiremagalur, G. Frankle, K. Fukuhara, I.J. Kopin, and E.L. Sabban Induction of tyrosine hydroxylase gene expression by a non-neuronal non-pituitary-mediated mechanism in immobilization stress Proc. Natl. Acad. Sci. U.S.A. 91 1994 5937 5941
26. B.B. Nankova, and E.L. Sabban Multiple signalling pathways exist in the stress-triggered regulation of gene expression for catecholamine biosynthetic enzymes and several neuropeptides in the rat adrenal medulla Acta Physiol. Scand. 167 1999 1 9
27. C.W. Olanow, and W.G. Tatton Etiology and pathogenesis of Parkinson's disease Annu. Rev. Neurosci. 22 1999 123 144
28. D.J. Reis, R.A. Ross, and T.H. Joh Changes in the activity and amounts of enzymes synthesizing catecholamines and acetylcholine in brain, adrenal medulla, and sympathetic ganglia of aged rat and mouse Brain Res. 136 1977 465 474
29. 2+-induced ERK activation mediated by reactive oxygen species causes cell death in differentiated PC12 cells J. Neurochem. 78 2001 600 610
30. T. Sharp, T. Zetterstrom, and U. Ungerstedt An in vivo study of dopamine release and metabolism in rat brain regions using intracerebral dialysis J. Neurochem. 47 1986 113 122
31. B. Theissen, A.H. Rajput, W. Laverty, and H. Desai Age, environments and the number of substantia nigra neurones M.B. Streifler A.D. Korezyn E. Melamed M.B.H. Youdim Advances in Neurology: Parkinson's Disease: Anatomy, Pathology, and Therapy 1990 Raven Press New York 201 206
32. I. Tooyama, E.G. McGeer, T. Kawamata, H. Kimura, and P.L. McGeer Retention of basic fibroblast growth factor immunoreactivity in dopaminergic neurones of the substantia nigra during normal ageing in humans contrasts with the loss in Parkinson's Disease Brain Res. 656 1994 165 168
33. V. Toth, M. Kummert, J. Sugar, and J. Knoll A procedure for measuring neuromelanin in neurocytes by a TV-image analyzer Mech. Ageing Dev. 63 1992 215 221
34. C. Tournier, P. Hess, D.D. Yang, J. Xu, T.K. Turner, A. Nimnual, D. Bar-Sagi, S.N. Jones, R.A. Flavell, and R.J. Davis Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway Science 288 2000 870 874
35. M. Verheij, R. Bose, X.H. Lin, B. Yao, W.D. Jarvis, S. Grant, M.J. Birrer, E. Szabo, L.I. Zon, J.M. Kyriakis, A. Haimovitz-Friedman, Z. Fuks, and R.N. Kolesnick Requirement for ceramide-initiated SAPK/JNK signaling in stress-induced apoptosis Nature 380 1996 75 79
36. H. Wilms, P. Rosenstiel, J. Sievers, G. Deuschl, L. Zecca, and R. Lucius Activation of microglia by human neuromelanin is NF-kappaB dependent and involves p38 mitogen-activated protein kinase: implications for Parkinson's disease FASEB J. 17 2003 500 502
37. M.E. Wolf, M.J. Zigmond, and G. Kapatos Tyrosine hydroxylase content of residual striatal dopamine nerve terminals following 6-hydroxydopamine administration: a flow cytometric study J. Neurochem. 53 1989 879 885
38. M.J. Zigmond, A.L. Acheson, M.K. Stachowiak, and E.M. Stricker Neurochemical compensation after nigrostriatal bundle injury in an animal model of preclinical parkinsonism Arch. Neurol. 41 1984 856 861